Clinical Trial Update: Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of DE-117 ophthalmic solution administered once daily and twice daily in primary open-angle glaucoma and ocular hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-117 Ophthalmic Solution (DE-117)

Snippet

Sponsor: Santen Inc. | Conditions: Primary Open-angle Glaucoma and Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-08-04